MedTrace Logo

Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw

NCT00646113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-11-18

Study results available
· View outcomes & findings →

Summary

To evaluate 5-year survival, functionality and safety for OsseoSpeed™ 3.0 mm diameter implant when used for single tooth crown in positions 12, 22, 31, 32, 41 and 42. The primary hypothesis is that implant survival after 5 years is equal to what has been observed with comparable implants in current literature.

Conditions

  • Jaw, Edentulous, Partially

Interventions

DEVICE

OsseoSpeed™ TX 3.0S

OsseoSpeed™ TX 3.0 mm diameter

Sponsors & Collaborators

  • Dentsply Sirona Implants and Consumables

    lead INDUSTRY

Principal Investigators

  • Pablo Galindo Moreno, Assoc. Prof. · University of Granada: School of Dentistry

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Denmark
  • Germany
  • Italy
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00646113 on ClinicalTrials.gov